Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
More news and success stories.
-
05 May 2023
See more Catalonia is the second European region attracting funding for Deep Tech startupsCatalonia is the second European region attracting funding for Deep Tech startups
-
02 May 2023
See more Catalonia's health startup ecosystem has increased investments by 87%, defying the global decline trendCatalonia's health startup ecosystem has increased investments by 87%, defying the global decline trend
-
27 Apr 2023
See more Barcelona will host Berry's new global center of excellence and circular innovationBarcelona will host Berry's new global center of excellence and circular innovation
-
25 Apr 2023
See more Barcelona will host LGT's digital development hubBarcelona will host LGT's digital development hub
